GENE ONLINE|News &
Opinion
Blog

BIO Asia–Taiwan 2020 Online + Live for the Opportunity to Share Your Company’s Achievements and Goals

by GeneOnline
Share To
 
 
 
If you’re a venture capital firm, a start-up enterprise, or even a well-established company, you will not want to miss this opportunity to engage with a richly targeted audience of global investors, deal-making partners, and future customers.

Join now to present at the BIO Asia–Taiwan 2020 Online + Live for the opportunity to share your company’s achievements and goals.

Most importantly, you can make the right connections and maximize meeting efficiency by leveraging the BIO One-on-One Partnering™ system! Presenting companies will receive full access to this platform, leading to increased visibility and more engagement opportunities with your target audience.

» Apply Now

Presentation slots fill up fast

Submit your application today!

 

BIO Asia-Taiwan 2020 Secretariat

 

register@taiwanbio.org.tw | www.bioasiataiwan.com | +886-2-7700-388

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Pfizer Partners with Renowned Life Sciences VC to Build Pipeline Projected to be Worth $7 Billion
2023-07-20
Forbion Secures $1.48 Billion For Its Newest Funds, With Plans To Grow Biotechs
2023-04-20
Biotech Start-ups May Face a Foreboding Prospect Following Silicon Valley Bank (SVB)’s Unsuspected Collapse
2023-03-14
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
EVENT
Scroll to Top